Find an Expert
Search
Menu
Help
Report an issue
AdaptiVax-CoV: A novel adaptable SARS-CoV2 VLP vaccine to produce broad humoral and T cell responses to S, E and M viral proteins
Grant number: 2013957
| Funding period: 2021 - 2023
Active
University of Melbourne Researchers
Joseph Torresi
Microbiology and Immunology
William Heath
Microbiology and Immunology
Elizabeth Vincan
Infectious Diseases
Jason Mackenzie
Microbiology and Immunology
«
‹
1
2
›
»